STOCK TITAN

Replimune Group (REPL): Montanova-affiliated investors report over 7% ownership

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Replimune Group, Inc. is reported as having significant ownership by investment manager Montanova Capital, LLC and related parties. Montanova Capital and Aaron Cowen each report beneficial ownership of 6,609,000 shares of common stock, representing 7.9% of the class, with shared voting and dispositive power over those shares. Averill Master Fund, Ltd. reports beneficial ownership of 5,610,970 shares, or 6.7% of the common stock, also on a shared voting and dispositive basis. All of the shares reported are directly owned by advisory clients of Montanova Capital, with only Averill Master Fund, Ltd. identified as holding more than 5% of the class. The reporting persons state they disclaim beneficial ownership except to the extent of their pecuniary interest.

Positive

  • None.

Negative

  • None.
Montanova beneficial ownership 6,609,000 shares Beneficially owned common stock reported for Montanova Capital, LLC
Montanova percent of class 7.9% Percent of Replimune common stock class attributed to Montanova Capital, LLC
Averill beneficial ownership 5,610,970 shares Beneficially owned common stock reported for Averill Master Fund, Ltd.
Averill percent of class 6.7% Percent of Replimune common stock class attributed to Averill Master Fund, Ltd.
Aaron Cowen beneficial ownership 6,609,000 shares Beneficially owned Replimune common shares reported for Aaron Cowen
Aaron Cowen percent of class 7.9% Percent of Replimune common stock class attributed to Aaron Cowen
beneficially own financial
"None of those advisory clients, other than Averill Master Fund, Ltd., may be deemed to beneficially own more than 5%"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
shared voting power financial
"Shared Voting Power 6,609,000.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 6,609,000.00"
pecuniary interest financial
"disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest"
parent holding company financial
"Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What percentage of Replimune Group, Inc. (REPL) does Montanova Capital report owning?

Montanova Capital, LLC reports beneficial ownership of 6,609,000 shares of Replimune common stock, representing 7.9% of the outstanding class, with shared voting and shared dispositive power over all of those shares.

How many Replimune (REPL) shares does Averill Master Fund, Ltd. beneficially own?

Averill Master Fund, Ltd. reports beneficial ownership of 5,610,970 shares of Replimune common stock, equal to 6.7% of the class, with shared voting and shared dispositive power over the same number of shares.

What is Aaron Cowen’s reported ownership stake in Replimune (REPL)?

Aaron Cowen is reported as beneficially owning 6,609,000 shares of Replimune common stock, representing 7.9% of the class, with shared voting and shared dispositive power over those shares and no sole voting or dispositive authority.

Who directly owns the Replimune (REPL) shares reported by Montanova Capital?

All securities reported are directly owned by advisory clients of Montanova Capital, LLC. Among those clients, only Averill Master Fund, Ltd. is identified as potentially beneficially owning more than 5% of Replimune’s common stock.

Do the reporting persons fully admit beneficial ownership of their Replimune (REPL) shares?

The reporting persons disclaim beneficial ownership of the Replimune securities except to the extent of their pecuniary interest, stating that the report should not be deemed an admission of beneficial ownership for any legal purpose.





76029N106

(CUSIP Number)
07/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Montanova Capital, LLC
Signature:/s/ Andrew Nathanson
Name/Title:Andrew Nathanson, General Counsel and Chief Compliance Officer
Date:08/06/2026
Averill Master Fund, Ltd.
Signature:/s/ Andrew Nathanson
Name/Title:Andrew Nathanson, Authorized Signatory
Date:08/06/2026
Aaron Cowen
Signature:/s/ Aaron Cowen
Name/Title:Aaron Cowen
Date:08/06/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification